Skip to contentSTARR KEVIN P — ALNYLAM PHARMACEUTICALS, INC. insider: 194 transactions · InsiderLensSTARR KEVIN P
- Director at ALNYLAM PHARMACEUTICALS, INC. · on record since Jun 2, 2006
- Director at HUMAN GENOME SCIENCES INC · on record since Oct 20, 2006
- Director at AGIOS PHARMACEUTICALS, INC. · on record since Jul 31, 2013
- 10% owner at Eleven Biotherapeutics, Inc. · on record since Feb 13, 2014
- Director at Larimar Therapeutics, Inc. · on record since Jun 26, 2014
- 10% owner at Larimar Therapeutics, Inc. · on record since Jun 26, 2014
- Director at SAGE FUND LP · on record since Jul 23, 2014
- 10% owner at SAGE FUND LP · on record since Jul 23, 2014
- 10% owner at AGIOS PHARMACEUTICALS, INC. · on record since Sep 12, 2014
- 10% owner at Blueprint Medicines Corp · on record since Apr 29, 2015
- 10% owner at Foundation Medicine, Inc. · on record since Apr 28, 2015
- Director at Global Blood Therapeutics, Inc. · on record since Aug 19, 2015
- 10% owner at Global Blood Therapeutics, Inc. · on record since Aug 19, 2015
- Director at MyoKardia Inc · on record since Oct 28, 2015
- 10% owner at MyoKardia Inc · on record since Oct 28, 2015
- 10% owner at CytomX Therapeutics, Inc. · on record since Oct 23, 2015
- 10% owner at Voyager Therapeutics, Inc. · on record since Nov 18, 2015
- 10% owner at Editas Medicine, Inc. · on record since Feb 8, 2016
- 10% owner at Jounce Therapeutics, Inc. · on record since Jan 26, 2017
- 10% owner at RHYTHM PHARMACEUTICALS, INC. · on record since Oct 11, 2017
- 10% owner at Allena Pharmaceuticals, Inc. · on record since Nov 6, 2017
- 10% owner at Neon Therapeutics, Inc. · on record since Jun 26, 2018
- 10% owner at CONSTAR INTERNATIONAL INC · on record since Jul 24, 2018
- 10% owner at Fulcrum Therapeutics, Inc. · on record since Jul 22, 2019
- 10% owner at Revolution Medicines, Inc. · on record since Feb 18, 2020
- 10% owner at PLIANT THERAPEUTICS, INC. · on record since Jun 9, 2020
- 10% owner at Nurix Therapeutics, Inc. · on record since Jul 29, 2020
- 10% owner at Relay Therapeutics, Inc. · on record since Jul 21, 2020
- 10% owner at Decibel Therapeutics, Inc. · on record since Feb 12, 2021
Insider trading activity of STARR KEVIN P
- Transactions on record
- 194
- since Jun 10, 2005
- Open-market buys
- 2
- $2.3M
- Open-market sells
- 34
- $152.3M
- Companies traded
- 14
- last filing Jun 16, 2023
Figures computed from official regulatory filings — methodology.
Companies where STARR KEVIN P has traded
- SAGE FUND LP45 tx · $38.9M · Jun 16, 2023
- Fulcrum Therapeutics, Inc.6 tx · $1.3M · Nov 12, 2021
- Jounce Therapeutics, Inc.6 tx · $17M · Jun 14, 2021
- CONSTAR INTERNATIONAL INC2 tx · $79.1K · Aug 24, 2018
- MyoKardia Inc16 tx · $71.4M · Mar 7, 2018
- CytomX Therapeutics, Inc.2 tx · $463.9K · Oct 19, 2017
- ALNYLAM PHARMACEUTICALS, INC.58 tx · $18.5M · Jun 6, 2017
- Blueprint Medicines Corp1 tx · $3M · Dec 21, 2016
- Global Blood Therapeutics, Inc.6 tx · $1.7M · Dec 20, 2016
Track record of STARR KEVIN P
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of STARR KEVIN P
Co-insiders of STARR KEVIN P
- LEVIN MARK JAllena Pharmaceuticals, Inc. +20
- TEPPER ROBERT IAllena Pharmaceuticals, Inc. +20
- Third Rock Ventures GP III, L.P.Decibel Therapeutics, Inc. +11
- Third Rock Ventures III, L.P.Decibel Therapeutics, Inc. +11
- TRV GP III, LLCDecibel Therapeutics, Inc. +11
- Third Rock Ventures GP II, L.P.Allena Pharmaceuticals, Inc. +6
- Third Rock Ventures GP, L.P.AGIOS PHARMACEUTICALS, INC. +6
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
5 tx · $93.7K · Sep 7, 2016
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 16, 2023 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Jun 17, 2022 | AwardD | 9,947 | 0.00 USD | $0 | SEC |
| Nov 12, 2021 | Other | -1,000,000 | — | — | SEC |
| Sep 24, 2021 | Other | -1,000,000 | — | — | SEC |
| Jun 17, 2021 | Buy | 17,842 | 56.05 USD | $1M | SEC |
| Jun 14, 2021 | Other | -1,500,000 | — | — | SEC |
| Jun 11, 2021 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Mar 3, 2021 | Sell | -1,450,000 | 11.75 USD | $17M | SEC |
| Jun 11, 2020 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Jul 22, 2019 | Other | 5,595,238 | — | — | SEC |
| Jul 22, 2019 | OtherD | 0 | 0.00 USD | $0 | SEC |
| Jul 22, 2019 | OtherD | -39,166,667 | 0.00 USD | $0 | SEC |
| Jul 22, 2019 | Buy | 81,250 | 16.00 USD | $1.3M | SEC |
| Jun 6, 2019 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Feb 14, 2019 | Sell | 0 | 0.00 USD | $0 | SEC |
| Aug 24, 2018 | OtherD | -51,032 | 0.00 USD | $0 | SEC |
| Aug 24, 2018 | Other | 51,032 | 1.55 USD | $79.1K | SEC |
| Jun 8, 2018 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Apr 19, 2018 | Sell | -35,000 | 169.25 USD | $5.9M | SEC |
| Apr 19, 2018 | Sell | -24,000 | 168.28 USD | $4M | SEC |
| Mar 7, 2018 | Other | -2,000,000 | — | — | SEC |
| Feb 20, 2018 | Other | -510,554 | — | — | SEC |
| Jan 5, 2018 | Sell | -816,326 | 42.00 USD | $34.3M | SEC |
| Dec 8, 2017 | Other | -2,000,000 | — | — | SEC |
| Oct 19, 2017 | Other | -1,000,000 | — | — | SEC |